Camber Capital Management’s Orthofix Medical OFIX Stock Holding History

Camber Capital Management’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-500,000	Closed	-$27.4M	–	35
2017 Q4	$27.4M	Sell	500,000 -875,000	-64%	-$45.4M	1.34%	23
2017 Q3	$65M	Sell	1,375,000 -125,000	-8%	-$5.89M	4.12%	9
2017 Q2	$69.7M	Hold	1,500,000	–	–	3.39%	14
2017 Q1	$57.2M	Hold	1,500,000	–	–	2.32%	15
2016 Q4	$54.3M	Hold	1,500,000	–	–	2.83%	17
2016 Q3	$64.2M	Hold	1,500,000	–	–	2.82%	14
2016 Q2	$63.6M	Hold	1,500,000	–	–	3.07%	11
2016 Q1	$62.3M	Hold	1,500,000	–	–	3.65%	9
2015 Q4	$58.8M	Hold	1,500,000	–	–	3.8%	11
2015 Q3	$50.6M	Hold	1,500,000	–	–	4.34%	8
2015 Q2	$49.7M	Hold	1,500,000	–	–	3.38%	13
2015 Q1	$53.8M	Buy	1,500,000 +250,000	+20%	+$7.86M	3.84%	10
2014 Q4	$37.6M	Buy	1,250,000 +39,836	+3%	+$1.17M	2.5%	17
2014 Q3	$37.5M	Buy	1,210,164 +1,091,481	+920%	+$36.2M	3.52%	12
2014 Q2	$4.3M	Buy	+118,683	New	+$3.84M	0.28%	41

Other funds holding OFIX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Camber Capital Management's OFIX Position: Q1 2018 in Review

Camber Capital Management sold out of Orthofix Medical (OFIX) in Q1 2018, closing a stake of 500,000 shares — an estimated $27.4M sold.

Camber Capital Management first reported a position in OFIX in Q2 2014 and held it in 15 quarters. The position peaked at $69.7M in Q2 2017. 178 funds tracked by Wall St. Rank hold OFIX as of Q1 2018.

Camber Capital Management reported no remaining Orthofix Medical position as of Q1 2018 after selling out during the quarter.
Camber Capital Management sold 500,000 Orthofix Medical shares in Q1 2018, an estimated $27.4M.
Camber Capital Management first reported a position in Orthofix Medical in Q2 2014 and held it in 15 quarters.
Camber Capital Management's Orthofix Medical position peaked at $69.7M in Q2 2017.
178 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2018.

Based on Camber Capital Management's 13F filing for Q1 2018, filed 15 May 2018.